Interventional Cardiology & Peripheral Vascular Devices Market is poised to grow at a CAGR of 7.8% & to reach $12.7 billion by 2016 - New Report by MarketsandMarkets

[475 Pages Report] Interventional Cardiology & Peripheral Vascular Devices Market consist of devices used in both coronary and peripheral endovascular procedures.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
MarketsandMarkets

MarketsandMarkets

Major players in the market include Abbott Vascular, Boston Scientific, Medtronic, Inc., C.R. Bard, Inc. (U.S.), B Braun, Inc. (Germany), Cook Medical (U.S.), Cordis Corp. (U.S.) & few more.

(PRWEB) March 24, 2013

The “Interventional Cardiology & Peripheral Vascular Devices Market (Balloons, EVAR Stent Grafts, IVC Filter, IVUS & Angiography Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices & Accessory Devices) Global Trends & Competitive Analysis” analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia and Rest of the World.

Browse

  • 213 Market Data Tables
  • 16 Figures
  • 475 Pages and an in-depth Table of Content on Interventional Cardiology & Peripheral Vascular Devices Market

http://www.marketsandmarkets.com/Market-Reports/interventional-cardiology-peripheral-vascular-devices-market-790.html

Early buyers will receive 10% customization on this report.

The vascular interventional devices market consists of devices used in both coronary and peripheral endovascular procedures such as balloons, EVAR stent grafts, IVC filters, IVUS & angiography catheters, plaque modification devices, hemodynamic flow alteration(HFA) devices and accessory devices. Coronary stent grafts hold the major share with 64.7% of the total market. The others include balloons with approximately 10% share and other accessory devices such as guide wires, catheters, HFA devices, etc. accounted for 30% share.

To treat conditions with less intervention to the patient, minimally invasive surgical procedures are increasingly being used since the last decade as an alternative to vascular surgery. The coronary and peripheral vascular market together contribute to this growth in interventional procedures. The peripheral angioplasty is expected to reach 3.3 million procedures by 2016, while coronary angioplasty procedures are estimated to reach 4.5 million procedures by 2016.

The major driving factor for these markets would be the increasing demand for minimally invasive percutaneous endovascular treatment. As the incidence cases of coronary and peripheral artery diseases continue to rise in the coming years along with increasing trends in co-morbid conditions such as obesity and diabetes, the Minimally Invasive Interventional Vascular Devices Market for treating these diseases would show significant growth in the forecast period.

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. They cover thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

Buy a copy of this report @ http://www.marketsandmarkets.com/Purchase/purchase_report1.asp?id=790

Contact:
Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441
Email: sales(at)marketsandmarkets(dot)com
Visit our Google Plus Profile
Connect with us on LinkedIn
Connect with us on Facebook


Contact

Follow us on: Contact's Facebook Contact's Twitter Contact's LinkedIn Contact's Google Plus